FMP
VRTX icon

Financial Management Professionals’s Vertex Pharmaceuticals VRTX Stock Holding History

Financial Management Professionals’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.7K Hold
80
– – ﹤0.01% 316
2026
Q1 		$35.7K Buy
80
+4
+5% +$1.86K ﹤0.01% 300
2025
Q4 		$34.5K Hold
76
– – ﹤0.01% 297
2025
Q3 		$29.8K Buy
76
+16
+27% +$6.69K ﹤0.01% 315
2025
Q2 		$26.7K Sell
60
-28
-32% -$12.9K ﹤0.01% 365
2025
Q1 		$42.7K Buy
88
+15
+21% +$6.99K 0.01% 284
2024
Q4 		$29.4K Buy
73
+3
+4% +$1.39K ﹤0.01% 342
2024
Q3 		$33K Buy
70
+4
+6% +$1.92K ﹤0.01% 330
2024
Q2 		$31K Hold
66
– – ﹤0.01% 325
2024
Q1 		$28K Sell
66
-10
-13% -$4.23K ﹤0.01% 365
2023
Q4 		$31K Buy
76
+13
+21% +$4.8K 0.01% 334
2023
Q3 		$22K Hold
63
– – ﹤0.01% 362
2023
Q2 		$22K Buy
63
+7
+13% +$2.36K ﹤0.01% 388
2023
Q1 		$18K Sell
56
-17
-23% -$5.1K ﹤0.01% 451
2022
Q4 		$21K Buy
73
+14
+24% +$4.27K ﹤0.01% 364
2022
Q3 		$17K Hold
59
– – ﹤0.01% 386
2022
Q2 		$17K Buy
59
+20
+51% +$5.35K ﹤0.01% 390
2022
Q1 		$10K Buy
39
+37
+1,850% +$8.78K ﹤0.01% 536
2021
Q4 		$0 Hold
2
– – ﹤0.01% 1101
2021
Q3 		$0 Hold
2
– – ﹤0.01% 1060
2021
Q2 		$0 Buy
+2
New +$418 ﹤0.01% 966
2021
Q1 		– Sell
-40
Closed -$9K – 723
2020
Q4 		$9K Sell
40
-139
-78% -$31.9K ﹤0.01% 386
2020
Q3 		$49K Sell
179
-1
-0.6% -$276 0.02% 208
2020
Q2 		$52K Buy
+180
New +$48.8K 0.02% 200

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Financial Management Professionals's VRTX Position: Q2 2026 in Review

Financial Management Professionals held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 80 shares worth $39.7K. The position accounts for ﹤0.01% of the portfolio, ranked #316.

Financial Management Professionals first reported a position in VRTX in Q2 2020 and has held it in 24 quarters since. The position peaked at $52K in Q2 2020. 324 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Financial Management Professionals held 80 shares of Vertex Pharmaceuticals worth $39.7K as of Q2 2026.
  • Financial Management Professionals left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Financial Management Professionals's portfolio in Q2 2026, its #316 holding.
  • Financial Management Professionals first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 24 quarters since.
  • Financial Management Professionals's Vertex Pharmaceuticals position peaked at $52K in Q2 2020.
  • 324 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.